- Malaysia’s first Covid-19 vaccine development is currently in the laboratory or proof of concept (POC) stage.
- The preliminary cost at the POC stage was anticipated to be about RM1 million to RM2 million, with the preclinical stage costing RM3 million to RM4 million.
Malaysia Is Currently Developing Own Covid-19 Vaccine Says MOH
According to the Dewan Rakyat, the country’s first COVID-19 vaccine development is currently in the laboratory or proof of concept (POC) stage.
Datuk Aaron Ago Dagang, Deputy Health Minister II, said that the vaccine development research encompassed virus inactivated technology like Sinovac and genetic sequencing or mRNA for the Pfizer vaccine.
He said that the vaccine was being fully developed by local specialists from the Institute of Medical Research (IMR) with the support of experts from Universiti Putra Malaysia and the Veterinary Research Institute.
“Producing this vaccine will take time to reach the levels of safety and effectiveness desired through phase three of the clinical trials and approval by the National Pharmaceutical Regulatory Agency (NRPA).”
“(COVID-19) vaccine research is a new field in this country and the vaccine can be used after the clinical trials on animals and humans show it to be safe and effective.”
He stated this in response to a query from Datuk Mohd Salim Sharif (BN-Jempol) during the Dewan Rakyat session on October 7 on the latest developments after Covid-19 vaccinations were given throughout the country last November.
source-drug target review
In response to Mohd Salim’s query on the cost of creating the vaccine, Aaron said that the preliminary cost at the POC stage was anticipated to be about RM1 million to RM2 million, with the preclinical stage costing RM3 million to RM4 million.
“After this, there will be various stages more in creating the vaccine, manufacturing and marketing it that will cost millions of ringgit, hence we hope this effort is not only supported with government funding but also the involvement of the private sector,” he added.